PT Prodia Widyahusada Tbk (IDX:PRDA)

Indonesia · Delayed Price · Currency is IDR

3,600.00

-40.00 (-1.10%)

Oct 30, 2026, 4:06 PM WIB

Market Cap	3.20T +32.4%
Revenue (ttm)	2.41T +8.0%
Net Income	218.09B +14.6%
EPS	244.77 +17.9%
Shares Out	889.78M
PE Ratio	14.71
Forward PE	14.41
Dividend	162.68 (4.52%)
Ex-Dividend Date	May 5, 2026

Volume	1,110,300
Open	3,650.00
Previous Close	3,640.00
Day's Range	3,560.00 - 3,650.00
52-Week Range	2,230.00 - 3,760.00
Beta	0.01
Analysts	n/a
Price Target	n/a
Est. Earnings	Mar 5, 2027

About PT Prodia Widyahusada Tbk

PT Prodia Widyahusada Tbk provides clinical laboratory services in Indonesia. The company offers test services, such as genomic, laboratory, and non-laboratory tests, as well as test panels; doctor consultation and teleconsultation services; vaccines; home services; and research support services. It also engages in the operation of Prodia Health Care, a personalized medicine-based wellness clinic; and specialty clinics, including Prodia Children, Prodia Women, and Prodia Senior. The company was founded in 1973 and is headquartered in Jakarta Pu... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1973

Employees 2,908

Stock Exchange Indonesia Stock Exchange

Ticker Symbol PRDA

Full Company Profile

Financial Performance

In 2025, PT Prodia Widyahusada Tbk's revenue was 2.28 trillion, an increase of 1.31% compared to the previous year's 2.25 trillion. Earnings were 206.79 billion, a decrease of -23.47%.

Financial Statements